Adaptive Biotechnologies (NASDAQ:ADPT) announces its next round of earnings this Wednesday, May 05. Here is Benzinga's everything-that-matters guide for this Wednesday's Q1 earnings announcement.

Net Income, Earnings, And Earnings Per Share

Earnings and especially earnings per share (EPS) are useful measures of a company's profitability. Total earnings, which is also referred to as net income, equals total revenue minus total expenses. EPS equals to net income divided by the number of shares outstanding.

Earnings And Revenue

Analysts covering Adaptive Biotechnologies have modeled for quarterly EPS loss of $0.41 on revenue of $27.75 million. In the same quarter last year, Adaptive Biotechnologies posted EPS of $0.25 on sales of $20.91 million.

What Are Analyst Estimates And Earnings Surprises, And Why Do They Matter?

The Wall Street estimate would represent a 64.0% decline in the company's earnings. Sales would be up 32.71% from the year-ago period. Here is how the company's reported EPS has stacked up against analyst estimates in the past:

Stock Performance

Shares of Adaptive Biotechnologies were trading at $38.02 as of May 03. Over the last 52-week period, shares are up 8.86%. Given that these returns are generally positive, long-term shareholders should be content going into this earnings release.

Do not be surprised to see the stock move on comments made during its conference call. Adaptive Biotechnologies is scheduled to hold the call at 16:30:00 ET and can be accessed here.